Where is the bar set for newer medications
According to IQVIA, this creates an unusually short branded exclusivity window: generic manufacturers are positioned to flood the market with lower-cost alternatives, potentially extending GLP-1 treatment to a far broader patient population
And our portfolio strategy, we think, is very solid when it comes to a potential protection against some of these future developments five or 10 years from now. Hartman Group: Surge of inquiries from CPG cos after Walmart pullback comment Right now, most food companies are just trying to understand what this all means, says Melissa Abbott, VP syndicated studies at Hartman Group, a market research and consulting firm that specializes in the food and beverage industry
The Ozempic multidistrict litigation is facing an unexpected complication due to the abrupt and tragic passing of U.S
[ref] Carnitine: The study on mice showing that carnitine transport is essential for GLP-1 RA effectiveness indicates that low carnitine levels may impair weight loss.[ref] More studies are needed, but it may be that adding supplemental carnitine could help, especially if you have genetic variants related to lower carnitine levels